The Current State-of-the-Art in Pharmacotherapy for Pediatric Generalized Anxiety Disorder

This systematic review synthesizes evidence-based pharmacotherapy for pediatric GAD, finding that combination psychotherapy and pharmacotherapy yields better outcomes than monotherapy. SSRIs are recommended as first-line treatment with faster symptom reduction, while SNRIs serve as a second-line option, both showing moderate effect sizes in clinical trials.